Furthermore, UCMSC-Exos suppress the secretion of cytokines such as IFN-γ, TNF-α, IL-6, interleukin-17A (IL-17A), and IL-17F, while enhancing the production of IL-10 and TGF-β in pSS patients (74). This evidence concerns the gene IL17A and peeling skin syndrome.